Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting
of fluorouracil, leucovorin, and gemcitabine in treating patients with recurrent or
metastatic colorectal cancer.